Press release
Preclinical Assets Market Forecast 2025-2034: Evaluating Growth Factors, Segments, and Emerging Trends
Preclinical Assets Market
The expansion of the preclinical asset market is anticipated to be fuelled by the surge in drug discovery. Drug discovery is the identification process of potential medicinal agents through chemical substances. This process leads to the unearthing of possible new drugs. Preclinical assets carry significant weight during this procedure as they provide crucial data and proof, assisting in picking molecules ready for clinical testing. For instance, the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based pharmaceutical sector representative, reported in June 2023 that there was considerable production growth in the European pharmaceutical industry. The figures escalated from $352.48 billion in 2021 to an impressive $369.95 billion in 2022. Consequently, the upswing in drug discovery is propelling the preclinical assets market's growth.
Get Your Preclinical Assets Market Report Here:
https://www.thebusinessresearchcompany.com/report/preclinical-assets-global-market-report
What is the future CAGR of the preclinical assets market, and how will it impact industry expansion?
The market size for preclinical assets has seen a substantial increase in recent years. It is projected to rise from $5.87 billion in 2024 to $6.4 billion in 2025, boasting a compound annual growth rate (CAGR) of 9.1%. The growth witnessed in the past years is due to factors such as the demand for drug development, advancements in biotechnology, regulatory obligations, growth in research funding, and joint research initiatives.
The size of the preclinical assets market is projected to experience robust expansion in the forthcoming years, swelling to a valuation of $9.3 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 9.8%. This projected growth through the anticipated period is attributable to several factors such as precision medicine and individualized treatments, incorporation of artificial intelligence and machine learning, expansion of biobanking, emphasis on rare diseases, and government support and financing initiatives. Furthermore, the forecast period will likely see the rise of advanced imaging techniques, 3D organoid models, multi-omics integration, improved predictive models, automation and high throughput screening.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12600&type=smp
How are the latest trends influencing the growth of the preclinical assets market?
The advent of product innovations is a critical trend gaining traction in the preclinical assets sector. Major corporations within this industry are working on the creation of novel products and solutions in a bid to solidify their standing and obtain a competitive edge. For example, in April 2022, Charles River Laboratories International - a U.S. pharmaceutical firm with specialisms in preclinical and clinical labs, collaborated with Valo Health Inc., an American tech firm dedicated to revolutionizing drug discovery, to introduce Logica, an AI-powered drug solution that effectively converts clients' biological insights into optimized preclinical assets. Logica employs Charles River's superior preclinical expertise and Valo's AI-enabled Opal Computational Platform to offer clients a revamped drug discovery process through one comprehensive offering that smoothly transitions targets to candidate nomination. By teaming up with Valo, Charles River blends its lab proficiency with molecular design technology, thereby bringing about industry revolution that provides clients with highly eligible leads and candidates while linking client costs to value generation.
Which key market segments comprise the preclinical assets market and drive its revenue growth?
The preclinical assets market covered in this report is segmented -
1) By Service: Bioanalysis And DMPK (Drug Metabolism And Pharmacokinetic) Studies, Toxicology Testing, Compound Management, Safety Pharmacology, Other Services
2) By Model Type: Patient Derived Organoid (PDO) Model, Patient Derived Xenograft Model
3) By End User: Biopharmaceutical Companies, Government Institutes, Other End-Users
Subsegments:
1) By Bioanalysis And DMPK (Drug Metabolism And Pharmacokinetic) Studies: Pharmacokinetics (PK) Studies, Pharmacodynamics (PD) Studies, Bioanalytical Method Development
2) By Toxicology Testing: Acute Toxicity Testing, Chronic Toxicity Testing, Genotoxicity Testing, Carcinogenicity Testing
3) By Compound Management: Compound Library Management, Sample Storage And Retrieval, High-Throughput Screening Support
4) By Safety Pharmacology: Cardiovascular Safety Assessments, Neurotoxicity Evaluations, Respiratory Safety Evaluations
5) By Other Services: Regulatory Support, Preclinical Study Design And Consulting, Custom Assay Development
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12600
What regions are at the forefront of preclinical assets market expansion?
North America was the largest region in the preclinical assets market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the preclinical assets market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Who are the leading players fueling growth in the preclinical assets market?
Major companies operating in the preclinical assets market include Laboratory Corporation of America, IQVIA Inc., ICON PLC, Eurofins Scientific SE, PPD Inc., SGS SA, WuXi AppTec Co. Ltd., Intertrek Group PLC, Charles River Laboratories International Inc., Medpace Inc., Pharmaron Beijing Co. Ltd., Evotec SE, GenScript Biotech Corporation, Inotiv Inc., SRI International Inc., Shanghai Medicilon Inc., Biocytogen Pharmaceuticals Beijing Co. Ltd., AmplifyBio LLC, BioReliance Corporation, Pharmalegacy Laboratories Co. Ltd., Precigen Inc., ReproCELL Incorporated, InSphero AG, Crown Bioscience Inc., Comparative Biosciences Inc., TCG Lifesciences Pvt. Ltd., InVivo Biosystems, Pharmatest Services Ltd, Domainex Limited, Viroclinics Xplore
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12600&type=smp
What Is Covered In The Preclinical Assets Global Market Report?
• Market Size Forecast: Examine the preclinical assets market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the preclinical assets market for a structured understanding.
• Key Players Overview: Analyze major players in the preclinical assets market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the preclinical assets market.
• Segment Contributions: Evaluate how different segments drive overall growth in the preclinical assets market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the preclinical assets market.
• Industry Challenges: Identify potential risks and obstacles affecting the preclinical assets market.
• Competitive Landscape: Review strategic developments in the preclinical assets market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Preclinical Assets Market Forecast 2025-2034: Evaluating Growth Factors, Segments, and Emerging Trends here
News-ID: 3898093 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Preclinical
Driving Preclinical CRO Market Growth in 2025: The Role of Surging Demand For Pr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Preclinical CRO Market Size Growth Forecast: What to Expect by 2025?
In recent times, there has been a significant increase in the size of the preclinical CRO market. The market will develop from being worth $5.7 billion in 2024 to achieving a value of $6.26 billion the following year,…
DLL3 Inhibitors in Preclinical and Clinical Studies
Delta-Like Ligand 3 (DLL3) inhibitors have shown significant promise in preclinical and clinical studies, particularly for the treatment of aggressive cancers such as small cell lung cancer (SCLC) and neuroendocrine tumors. The selective expression of DLL3 in these malignancies makes it an attractive target for therapeutic intervention. This article explores the development and progress of DLL3 inhibitors in preclinical and clinical studies, highlighting their potential in modern oncology.
Download Report:
https://www.kuickresearch.com/report-dll3-targeted-therapies-dll3-cancer-therapies-dll3-protien-dll3-cancer-drugs-delta-like-ligand-3-dll3-gene-dll3-expression-dll3-amgen-dll3-inhibitor
DLL3…
Preclinical CRO Market Size Forecast Between 2023-2032
The global market for Preclinical Contract Research Organizations (CROs) has witnessed substantial growth in recent years, driven by increasing outsourcing of preclinical research activities by pharmaceutical and biotechnology companies. In 2022, the market size reached USD 5.2 Billion and is projected to grow to USD 10.7 Billion by 2032, with a compound annual growth rate (CAGR) of 7.6% from 2023 to 2032. This article delves into the current trends, drivers,…
Preclinical Imaging Market Opportunity | Size | Research Report
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- Preclinical Imaging Market was valued at USD 748.18 Million in 2023 and is projected to reach USD 1,109.10 Million by 2030, growing at a CAGR of 5.0% from 2024 to 2030.
The preclinical imaging market is being significantly driven by advancements in imaging modalities, such as MRI, PET, SPECT, CT, and optical imaging. These technologies provide researchers with non-invasive ways to visualize and study biological processes at the…
Preclinical Imaging Market - Transforming Research with Precision Imaging: Precl …
Newark, New Castle, USA: The "Preclinical Imaging Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Preclinical Imaging Market: https://www.growthplusreports.com/report/preclinical-imaging-market/7673
This latest report researches the industry structure, sales, revenue,…
Preclinical Imaging Market - Unlocking Clarity, Preserving Scientific Excellence …
Newark, New Castle, USA - new report, titled Preclinical Imaging Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Preclinical Imaging market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Preclinical Imaging market. The report offers an overview of the market, which…
